Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acadia Pharmaceuticals
Pharma
Acadia gives up on future Nuplazid studies after latest flop
The company will not conduct any further clinical trials of the drug, which is currently approved for Parkinson’s disease psychosis.
Zoey Becker
Mar 12, 2024 11:58am
Acadia's Daybue becomes first treatment for Rett syndrome
Mar 13, 2023 11:27am
Acadia launches Rett syndrome campaign featuring artist’s mosaic
Oct 7, 2022 10:40am
Acadia's Nuplazid gets second FDA complete response letter
Aug 5, 2022 11:26am
Lundbeck, Otsuka drug cut agitation in Alzheimer's patients
Jun 27, 2022 11:44am
FDA panelists vote down Acadia's proposed Nuplazid expansion
Jun 21, 2022 11:00am